ID |
PMID |
Sequence |
Chirality |
Peptide name |
Origin |
Family |
Nature |
Sub-cellular localization |
N terminal modification |
C terminal modification |
Uptake efficiency |
Uptake mechanism |
Cancer cell lines |
Patent number |
|
1001 | 9188504 | GRKKRRQRRRPPQ | L | Tat (48-60) | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus, nucelolus | Labelled with Cys-acetamidomethyl | Labelled with fluorescein maleimide | High | Non-endocytic pathway | HeLa | US 20040132970 |
|
1002 | 9188504 | LGISYGRKKRRQRRRPPQ | L | Tat (43-60) | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus, nucelolus | Labelled with Cys-acetamidomethyl | Labelled with fluorescein maleimide | High | Non-endocytic pathway | HeLa | US 6740524 |
|
1003 | 9188504 | FITKALGISYGRKKRRQRRRPPQ | L | Tat (37-60) | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus, nucelolus | Labelled with Cys-acetamidomethyl | Labelled with fluorescein maleimide | High | Non-endocytic pathway | HeLa | Unknown |
|
1004 | 9188504 | FITKALGISYGRKKRR | L | Tat (37-53) | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus, nucelolus | Labelled with Cys-acetamidomethyl | Labelled with fluorescein maleimide | Low | Non-endocytic pathway | HeLa | Unknown |
|
1005 | Unknown | GRKKRRQRRR | L | Tat (48-57) | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus, nucelolus | Labelled with Cys-acetamidomethyl | Labelled with fluorescein maleimide | High | Non-endocytic pathway | HeLa | US 20100216716 |
|
1006 | 11087855 | RKKRRQRRR | L | Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | High | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1007 | 11087855 | RKKRRQRR | L | Tat (49-56) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Medium (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1008 | 11087855 | RKKRRQR | L | Tat (49-55) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1009 | 11087855 | KKRRQRRR | L | Tat (50-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1010 | 11087855 | KRRQRRR | L | Tat (51-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1011 | 11087855 | rkkrrqrrr | D | D-Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | High (greater than Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1012 | 11087855 | RRRQRRKKR | L | Retro - Tat (57-49) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | High (greater than Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1013 | 11087855 | rrrqrrkkr | D | D-Tat (57-49) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | High (greater than Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1014 | 11087855 | AKKRRQRRR | L | Ala49 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1015 | 11087855 | RAKRRQRRR | L | Ala50 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1016 | 11087855 | RKARRQRRR | L | Ala51 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1017 | 11087855 | RKKARQRRR | L | Ala52 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1018 | 11087855 | RKKRAQRRR | L | Ala53 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1019 | 11087855 | RKKRRARRR | L | Ala54 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Medium (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1020 | 11087855 | RKKRRQARR | L | Ala55 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1021 | 11087855 | RKKRRQRAR | L | Ala56 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1022 | 11087855 | RKKRRQRRA | L | Ala57 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1023 | Unknown | GRKKRRQRRPPQC | L | Arg deletion mutant of Tat (48-60) | HIV-1 | Protein derived | Cationic | Nucleus and nucleolus | Free | Labelled with fluorescein | Medium (50 % relative to Tat (48-60)) | Probably non-endocytic pathway | HeLa | Unknown |
|
1024 | Unknown | GRKKRRQRPPQC | L | Arg deletion mutant of Tat (48-60) | HIV-1 | Protein derived | Cationic | Nucleus and nucleolus | Free | Labelled with fluorescein | Low (25 % relative to Tat (48-60)) | Probably non-endocytic pathway | HeLa | Unknown |
|
1025 | Unknown | GRKKRRQPPQC | L | Arg deletion mutant of Tat (48-60) | HIV-1 | Protein derived | Cationic | Nucleus and nucleolus | Free | Labelled with fluorescein | Low (10 % relative to Tat (48-60)) | Probably non-endocytic pathway | HeLa | Unknown |
|
1026 | Unknown | GRKKRRQRRRC | L | Pro deletion mutant of Tat (48-60) | HIV-1 | Protein derived | Cationic | Nucleus and nucleolus | Free | Labelled with fluorescein | Medium (80 % relative to Tat (48-60)) | Probably non-endocytic pathway | HeLa | Unknown |
|
1027 | Unknown | GRKKRRQRARPPQC | L | Ala substitution mutant of Tat (48-60) | HIV-1 | Protein derived | Cationic | Nucleus and nucleolus | Free | Labelled with fluorescein | Medium (35 % relative to Tat (48-60)) | Probably non-endocytic pathway | HeLa | Unknown |
|
1028 | Unknown | GRKKRRQARAPPQC | L | Ala substitution mutant of Tat (48-60) | HIV-1 | Protein derived | Cationic | Nucleus and nucleolus | Free | Labelled with fluorescein | Low (15 % relative to Tat (48-60)) | Probably non-endocytic pathway | HeLa | Unknown |
|
1029 | 11084031 | TRQARRNRRRRWRERQR | L | Rev (34-50) | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Cystein amide labelled with fluorescein | High (comparable to Tat (48-60) | Non-endocytic pathway | RAW 264.7 | US 20060223752 |
|
1030 | 11084031 | RRRR | L | R4 | Positively charged sequence | Synthetic | Cationic | Cytoplasm and nucleus | Free | C-terminal Cystein amide labelled with fluorescein | Very low | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1031 | 11087855 | RRRRR | L | R5 | Positively charged sequence | Synthetic | Cationic | Cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1032 | 11087855 | RRRRRR | L | R6 | Positively charged sequence | Synthetic | Cationic | Cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | Medium (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1033 | 11087855 | RRRRRRR | L | R7 | Positively charged sequence | Synthetic | Cationic | Cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | High (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1034 | 11087855 | RRRRRRRR | L | R8 | Positively charged sequence | Synthetic | Cationic | Cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | High (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1035 | 11087855 | RRRRRRRRR | L | R9 | Positively charged sequence | Synthetic | Cationic | Cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | High (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1036 | 11084031 | RRRRRRRRRRR | L | R10 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | High, less than R8 | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1037 | 11084031 | RRRRRRRRRRRR | L | R12 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Low | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1038 | 11084031 | RRRRRRRRRRRRRRRR | L | R16 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Low | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1039 | 11087855 | rrrrr | D | D-R5 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1040 | 11087855 | rrrrrr | D | D-R6 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | High (comparable to Tat (49-57) and higher than R6 | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1041 | 11087855 | rrrrrrr | D | D-R7 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | High (relative to both Tat (49-57) and R7) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1042 | 11087855 | rrrrrrrr | D | D-R8 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | High (relative to both Tat (49-57) and R7) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1043 | 11087855 | rrrrrrrrr | D | D-R9 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | High (relative to both Tat (49-57) and R7) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
1044 | 10930519 | GWTLNSAGYLLGKINLKALAALAKKIL | L | Transportan (TP) | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylation | Free | High | Non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1045 | 10930519 | GWTLNSAGYLLGKINLKALAALAKKLL | L | TP2 | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylated at amino group of Lys | Free | Unknown | Probably non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1046 | 10930519 | GWTLNSAGYLLGKFLPLILRKIVTAL | L | TP4 | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylated at amino group of Lys | Free | Unknown | Probably non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1047 | 10930519 | GWTLNPAGYLLGKINLKALAALAKKIL | L | TP5 | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylated at amino group of Lys | Free | Unknown | Probably non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1048 | 10930519 | GWTLNPPGYLLGKINLKALAALAKKIL | L | TP6 | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylated at amino group of Lys | Free | Unknown | Probably non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1049 | 10930519 | LNSAGYLLGKINLKALAALAKKIL | L | TP7 | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylated at amino group of Lys | Free | Comparable to Transportan | Probably non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1050 | 10930519 | LLGKINLKALAALAKKIL | L | TP8 | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylated at amino group of Lys | Free | Very low relative to Transportan | Probably non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1051 | 10930519 | GWTLNSAGYLLGKLKALAALAKKIL | L | TP9 | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylated at amino group of Lys | Free | Comparable to Transportan | Probably non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1052 | 10930519 | AGYLLGKINLKALAALAKKIL | L | TP10 | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylated at amino group of Lys | Free | Comparable to Transportan | Probably non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1053 | 10930519 | GWTLNSKINLKALAALAKKIL | L | TP11 | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylated at amino group of Lys | Free | Lower than Transportan | Probably non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1054 | 10930519 | LNSAGYLLGKLKALAALAKIL | L | TP12 | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylated at amino group of Lys | Free | Lower than Transportan | Probably non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1055 | 10930519 | LNSAGYLLGKALAALAKKIL | L | TP13 | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylated at amino group of Lys | Free | Very low relative to Transportan | Probably non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1056 | 10930519 | AGYLLGKLKALAALAKKIL | L | TP14 | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylated at amino group of Lys | Free | Lower than Transportan | Probably non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1057 | 10930519 | LNSAGYLLGKLKALAALAK | L | TP15 | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylated at amino group of Lys | Free | Very low relative to Transportan | Probably non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1058 | 10930519 | GWTLNSAGYLLGKINLKAPAALAKKIL | L | TP16 | Fusion of Neropeptide Galanin and wasp venom pepti | Chimeric | Amphipathic | Cytoplasm and nucleus and intracellular membranous structures | Biotinylated at amino group of Lys | Free | Unknown | Probably non-receptor mediated endocytic pathway | Human bowes melanoma cells | Unknown |
|
1061 | 10323198 | KLALKLALKALKAALKLA | L | I | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | High (pmol internalized peptide/mg protein = 228) | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1062 | 10323198 | KLALKLALKAWKAALKLA | L | KLA1 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Medium relative to I (pmol internalized peptide/mg | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1063 | 10323198 | KLALKAALKAWKAAAKLA | L | KLA2 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Low relative to I (pmol internalized peptide/mg pr | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1064 | 10323198 | KLALKAAAKAWKAAAKAA | L | KLA3 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Low relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1065 | 10323198 | KITLKLAIKAWKLALKAA | L | KLA11 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Low relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1066 | 10323198 | KIAAKSIAKIWKSILKIA | L | KLA5 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Low relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1067 | 10323198 | KALAKALAKLWKALAKAA | L | KLA12 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Medium relative to I (pmol internalized peptide/mg | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1068 | 10323198 | KLALKLALKWAKLALKAA | L | KLA13 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Low relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1069 | 10323198 | KLLAKAAKKWLLLALKAA | L | KLA14 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Low relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1070 | 10323198 | KLLAKAALKWLLKALKAA | L | KLA9 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Low relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1071 | 10323198 | KALKKLLAKWLAAAKALL | L | KLA10 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | High and comparable to I (pmol internalized peptid | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1072 | 10323198 | KLAAALLKKWKKLAAALL | L | KLA15 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | High and comparable to I (pmol internalized pepti | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1073 | 10323198 | KALAALLKKWAKLLAALK | L | KLA8 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | High and comparable to I (pmol internalized pepti | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1074 | 10323198 | KALAALLKKLAKLLAALK | L | II | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Labelled with fluorescein | Amidation | High relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1075 | 10323198 | KLALKLALKALKAALK | L | III | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Comparable to I (pmol internalized peptide/mg prot | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1076 | 10323198 | KLALKALKAALKLA | L | IV | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Low relative to I (pmol internalized peptide/mg pr | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1077 | 10323198 | KLALKLALKALKAA | L | V | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Low relative to I (pmol internalized peptide/mg pr | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1078 | 10323198 | KLGLKLGLKGLKGGLKLG | L | VI | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Low relative to I (pmol internalized peptide/mg pr | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1079 | 10323198 | KLALKLALKALQAALQLA | L | VII | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Low relative to I (pmol internalized peptide/mg pr | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1080 | 10323198 | KLALQLALQALQAALQLA | L | VIII | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | High relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1081 | 10323198 | QLALQLALQALQAALQLA | L | IX | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | High relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1082 | 10323198 | ELALELALEALEAALELA | L | X | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Low relative to I (pmol internalized peptide/mg pr | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1083 | 10323198 | LKTLATALTKLAKTLTTL | L | XI | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | High relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1084 | 10323198 | LLKTTALLKTTALLKTTA | L | XII | Designed Model peptide | Synthetic | Non-amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Unknown | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1085 | 10323198 | LKTLTETLKELTKTLTEL | L | XIII | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Low relative to I (pmol internalized peptide/mg pr | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1086 | 10323198 | LLKTTELLKTTELLKTTE | L | XIV | Designed Model peptide | Synthetic | Non-amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Unknown | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1087 | 10323198 | RQIKIWFQNRRMKWKK | L | XV | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Unknown | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1088 | 10998065 | klalklalkalkaalkla | D | D form of KLA | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Unknown | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1089 | 10998065 | KALKLKLALALLAKLKLA | L | Derivative of KLA1 | Designed Model peptide | Synthetic | Non-amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Unknown | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
1090 | 8663410 | RQIKIWFQNRRMKWKK | L | pAntpHD (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Cytoplasm and nucleus | Biotinylation | Amidation | High | Non-receptor mdiated endocytic pathway | Cortical striatal cells | Unknown |
|
1091 | 8663410 | KKWKMRRNQFWIKIQR | L | pAntpHD (58-43) | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Cytoplasm and nucleus | Biotinylation | Amidation | Similar to (pAntp) (43-58) | Non-receptor mdiated endocytic pathway | Cortical striatal cells | Unknown |
|
1092 | 8663410 | rqikiwfqnrrmkwkk | D | D form of pAntpHD (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Cytoplasm and nucleus | Biotinylation | Amidation | Similar to (pAntp) (43-58) | Non-receptor mdiated endocytic pathway | Cortical striatal cells | Unknown |
|
1093 | 8663410 | RQIKIWFPNRRMKWKK | L | pAntpHD (Pro50) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Cytoplasm | Biotinylation | Amidation | High, comparbale to (pAntp) (43-58) | Non-receptor mdiated endocytic pathway | Cortical striatal cells | Unknown |
|
1094 | 8663410 | RQPKIWFPNRRKPWKK | L | pAntpHD (3Pro) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Cytoplasm | Biotinylation | Amidation | Similar to (pAntp) (43-58) | Non-receptor mdiated endocytic pathway | Cortical striatal cells | Unknown |
|
1095 | 10784032 | RQIKIWFQNRRMKWKK | L | pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1096 | 10784032 | RQIKIWFQNRRMKWK | L | pAntp (43-57) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (55% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1097 | 10784032 | RQIKIWFQNRRMKW | L | pAntp (43-56) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (50% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1098 | 10784032 | RQIKIWFQNRRMK | L | pAntp (43-55) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (30% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1099 | 10784032 | RQIKIWFQNRRM | L | pAntp (43-54) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (20% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1100 | 10784032 | RQIKIWFQNRR | L | pAntp (43-53) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (25% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1101 | 10784032 | RQIKIWFQNR | L | pAntp (43-52) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (15% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1102 | 10784032 | RQIKIWFQN | L | pAntp (43-51) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (20% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1103 | 10784032 | RQIKIWFQ | L | pAntp (43-50) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (15% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1104 | 10784032 | RQIKIW | L | pAntp (43-48) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (20% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | Unknown |
|
1105 | 10784032 | QIKIWFQNRRMKWKK | L | pAntp (44-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High (85% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1106 | 10784032 | IKIWFQNRRMKWKK | L | pAntp (45-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High (95% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1107 | 10784032 | KIWFQNRRMKWKK | L | pAntp (46-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (65% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1108 | 10784032 | IWFQNRRMKWKK | L | pAntp (47-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (50% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1109 | 10784032 | WFQNRRMKWKK | L | pAntp (48-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (55% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1110 | 10784032 | FQNRRMKWKK | L | pAntp (49-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (65% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1111 | 10784032 | QNRRMKWKK | L | pAntp (50-58) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (60% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1112 | 10784032 | NRRMKWKK | L | pAntp (51-58) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (60% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1113 | 10784032 | RRMKWKK | L | pAntp (52-58) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (50% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1114 | 10784032 | RMKWKK | L | pAntp (53-58) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (25% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | Unknown |
|
1115 | 10784032 | AQIKIWFQNRRMKWKK | L | Ala43 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High (90% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1116 | 10784032 | RAIKIWFQNRRMKWKK | L | Ala44 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (65% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1117 | 10784032 | RQAKIWFQNRRMKWKK | L | Ala45 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High (80% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1118 | 10784032 | RQIAIWFQNRRMKWKK | L | Ala46 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (50% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1119 | 10784032 | RQIKAWFQNRRMKWKK | L | Ala47 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (55% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1120 | 10784032 | RQIKIAFQNRRMKWKK | L | Ala48 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (65% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1121 | 10784032 | RQIKIWAQNRRMKWKK | L | Ala49 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High (90% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1122 | 10784032 | RQIKIWFANRRMKWKK | L | Ala50 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High (90% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1123 | 10784032 | RQIKIWFQARRMKWKK | L | Ala51 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (60% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1124 | 10784032 | RQIKIWFQNARMKWKK | L | Ala52 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (45% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1125 | 10784032 | RQIKIWFQNRAMKWKK | L | Ala53 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (30% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1126 | 10784032 | RQIKIWFQNRRAKWKK | L | Ala54 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High (90% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1127 | 10784032 | RQIKIWFQNRRMAWKK | L | Ala55 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (25% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1128 | 10784032 | RQIKIWFQNRRMKAKK | L | Ala56 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (40% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1129 | 10784032 | RQIKIWFQNRRMKWAK | L | Ala57 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (20% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1130 | 10784032 | RQIKIWFQNRRMKWKA | L | Ala58 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (20% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
1131 | 10784032 | CRQIKIWFPNRRMKWKKC | L | Reduced linear penetratin | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Unknown | Labeled with Biotinyl-Ahx | Unknown | Unknown | Non-endocytic pathway | HaCat/ A549 cells | Unknown |
|
1132 | 10784032 | RQIKIWFPNRRMKWKK | L | Penetratin (pAntp) (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Cytosol and nucleus, nucleoi | Labeled with fluorescein | Amidation | Unknown | Non-endocytic pathway | HaCat/ A549 cells | Unknown |
|
1133 | 12849987 | RQIKIWFQNRRMKWKK | L | Penetratin (pAntp) (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Uneven distribution of peptide with accumulation in centrosmal area and in | Labeled with fluorescein | Amidation | Unknown | Endocytic pathway | PC-12 and V79 cells | US 7153931 |
|
1134 | 12849987 | RQIKIFFQNRRMKFKK | L | Pen2W2F | Antennapedia homeodomain of drosophila | Protein derived | Cationic | Uneven distribution of peptide with accumulation in centrosmal area and in | Labeled with fluorescein | Amidation | High and comparable to (pAntp) (43-58) | Endocytic pathway | PC-12 and V79 cells | Unknown |
|
1135 | 12849987 | RQIRIWFQNRRMRWRR | L | PenArg | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Uneven distribution of peptide with accumulation in centrosmal area and in | Labeled with fluorescein | Amidation | High and comparable to (pAntp) (43-58) | Energy-independent endocytic pathway | PC-12 and V79 cells | Unknown |
|
1136 | 12849987 | RRRRRRRW | L | R7W | Positively charged sequence | Synthetic | Cationic | Cytoplasm and nucleus | Labeled with fluorescein | Amidation | Unknown | Energy-independent non-endocytic pathway | PC-12 and V79 cells | Unknown |
|
1137 | 12849987 | GRKKRRQRRRPWQ | L | TatP59W | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus | Labeled with fluorescein | Amidation | Comparable to that of (pAntp) (43-58) | Endocytic pathway | PC-12 cells | Unknown |
|
1138 | 12849987 | GRKKRRQRRRPWQ | L | TatP59W | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus | Labeled with fluorescein | Amidation | Comparable to that of (pAntp) (43-58) | Non-endocytic pathway | V79 cells | Unknown |
|
1142 | 21319732 | KMDCRWRWKCCKK | L | Crot (27-39) | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | High (78% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1143 | 21319732 | MDCRWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | High (83% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1144 | 21319732 | DCRWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (47% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1145 | 21319732 | CRWRWKCCKK | L | CyLoP-1 | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | High (greater than Tat, penetratin and R8) | Receptor mediated endocytic process | NIH-3T3, CCL-11, C6 glioma cells and PANC-1 | US20110027300 |
|
1146 | 21319732 | RWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (37% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1147 | 21319732 | KMDCRWRWKCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | High (79% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1148 | 21319732 | KMDCRWRWKKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (30% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1149 | 21319732 | KMDRWRWKKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (2% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1150 | 21319732 | KDCRWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (26% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1151 | 21319732 | KCRWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (39% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1152 | 21319732 | KRWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (30% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1153 | 21319732 | MDCRWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (48% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1154 | 21319732 | DCRWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (43% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1155 | 21319732 | DCRWRWKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (23%of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1156 | 21319732 | CRWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (50% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1157 | 21319732 | CRWRWKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (33% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1158 | 21319732 | RWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (30% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1159 | 21319732 | MDCRWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (31% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1160 | 21319732 | DCRWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (22% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1161 | 21319732 | CRWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (34% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1162 | 21319732 | RWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (10% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1163 | 21319732 | CRWRWKCSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (54% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1164 | 21319732 | SRWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (46% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1165 | 21319732 | SRWRWKCSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (14% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1166 | 21319732 | SRWRWKSCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (12% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1167 | 21319732 | CRWRWKSSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (10% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1168 | 21319732 | SRWRWKSSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (5% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1169 | 21319732 | CRFRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (66% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1170 | 21319732 | CRWRFKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (61% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1171 | 21319732 | CRFRFKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (63% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1172 | 21319732 | crwrwkcckk | D | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (52% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1173 | 21319732 | KCCKWRWRCK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (42% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1174 | 21319732 | kcckwrwrck | D | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (36% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1175 | 21319732 | CrWRWKCCKK | M | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (38% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1176 | 21319732 | CRwRWKCCKK | M | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (30% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1177 | 21319732 | CRWrWKCCKK | M | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (32% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1178 | 21319732 | CRWRwKCCKK | M | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (35% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1179 | 21319732 | CrwrwKCCKK | M | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (37% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1180 | 21319732 | CRWRWKCGCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (59% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1181 | 21319732 | KCGCRWRWKCGCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | High (75% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1182 | 21319732 | CRWRWKCG | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (47% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1183 | 21319732 | KMDXRWRWKCCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (48% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1184 | 21319732 | KMDXRWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (18% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1185 | 21319732 | KMDXRWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (4% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1186 | 21319732 | KMDXRWRWKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (70% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1187 | 21319732 | MDCRWRWKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (38% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1188 | 21319732 | KMDCRWRWKCSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (58% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1189 | 21319732 | KMDCRWRWKSCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (29% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1190 | 21319732 | KMDSRWRWKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (24% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1191 | 21319732 | KMDCRWRWKSSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (15% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1192 | 21319732 | KMDSRWRWKSSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (12% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1193 | 21319732 | KMDSRWRWKSCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (21% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1194 | 21319732 | KMDSRWRWKCSKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (31% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1195 | 21319732 | KMDCRWRPKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (31% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1196 | 21319732 | KMDCRPRPKCCKK | L | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (9% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1197 | 21319732 | KMDXRPRPKCCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (6% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1198 | 21319732 | KMDXRPRPKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (5% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1199 | 21319732 | KMDXRPRPKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (6% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1200 | 21319732 | KMDCRPRPKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (7% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1201 | 21319732 | KMDCRPRPKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (9% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
1202 | 21319732 | RQIKIWFQNRRMKWKK | L | Penetratin (pAntp) | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Vesicles | Labelled with K-FITC or k-FITC at N-terminus | Free | Lower than CyLoP1 | Probably endocytic process | NIH-3T3 | Unknown |
|
1203 | 21319732 | rkkrrqrrr | D | Tat (49-57) | HIV-1 | Protein derived | Cationic | Vesicles | Labelled with K-FITC or k-FITC at N-terminus | Free | Lower than CyLoP1 | Probably endocytic process | NIH-3T3 | Unknown |
|
1204 | 21319732 | rrrqrrkkr | D | Tat (57-49) | HIV-1 | Protein derived | Cationic | Vesicles | Labelled with K-FITC or k-FITC at N-terminus | Free | Lower than CyLoP1 | Probably endocytic process | NIH-3T3 | Unknown |
|
1205 | 21319732 | rrrrrrrr | D | R8 | Positively charged sequence | Synthetic | Cationic | Vesicles | Labelled with K-FITC or k-FITC at N-terminus | Free | Lower than CyLoP1 | Probably endocytic process | NIH-3T3 | Unknown |
|
1206 | 15859953 | RKKRRRESRKKRRRES | L | DPV3 | Human Superoxide dismutase | Protein derived (Vectocell penetrating peptide fam | Unknown | Cytoplasm | Cys added to N -terminus for conjugation of report | Free | Higher than other DPVs and Tat (48-60) | Energy-dependent endocytic process involving cell membrane lipid rafts | HeLa, HCT116, HL-60, K562, Molt4, NIH-3T3 and primary hepatocyte cultures | Unknown |
|
1207 | 15859953 | GRPRESGKKRKRKRLKP | L | DPV6 | Human platelet-derived growth factor | Protein derived (Vectocell penetrating peptide fam | Unknown | Cytoplasm | Cys added to N -terminus for conjugation of report | Free | Unknown | Energy-dependent endocytic process involving cell membrane lipid rafts | HeLa, HCT116, HL-60, K562, Molt4, NIH-3T3 and primary hepatocyte cultures | Unknown |
|
1208 | 15859953 | GKRKKKGKLGKKRDP | L | DPV7 | Human Epidermal-like growth factor | Protein derived (Vectocell penetrating peptide fam | Unknown | Cytoplasm | Cys added to N -terminus for conjugation of report | Free | Unknown | Energy-dependent endocytic process involving cell membrane lipid rafts | HeLa, HCT116, HL-60, K562, Molt4, NIH-3T3 and primary hepatocyte cultures | Unknown |
|
1209 | 15859953 | GKRKKKGKLGKKRPRSR | L | DPV7b | Huamn Epidermal-like growth factor | Protein derived (Vectocell penetrating peptide fam | Unknown | Cytoplasm | Cys added to N -terminus for conjugation of report | Free | Unknown | Energy-dependent endocytic process involving cell membrane lipid rafts | HeLa, HCT116, HL-60, K562, Molt4, NIH-3T3 and primary hepatocyte cultures | Unknown |
|
1210 | 15859953 | RKKRRRESRRARRSPRHL | L | DPV3/10 | Human Superoxide dismutase and intestinal mucin | Protein derived (Vectocell penetrating peptide fam | Unknown | Cytoplasm | Cys added to N -terminus for conjugation of report | Free | Unknown | Energy-dependent endocytic process involving cell membrane lipid rafts | HeLa, HCT116, HL-60, K562, Molt4, NIH-3T3 and primary hepatocyte cultures | Unknown |
|
1211 | 15859953 | SRRARRSPRESGKKRKRKR | L | DPV10/6 | Human Intestinal mucin and PDGF | Protein derived (Vectocell penetrating peptide fam | Unknown | Cytoplasm | Cys added to N -terminus for conjugation of report | Free | Unknown | Energy-dependent endocytic process involving cell membrane lipid rafts | HeLa, HCT116, HL-60, K562, Molt4, NIH-3T3 and primary hepatocyte cultures | Unknown |
|
1212 | 15859953 | VKRGLKLRHVRPRVTRMDV | L | DPV1047 | Human Apolipoprotein B and anti-DNA antibody | Protein derived (Vectocell penetrating peptide fam | Unknown | Nucleus | Cys added to N -terminus for conjugation of report | Free | Lower than other DPVs and tat (48-60) | Energy-dependent caveolar endocytic independent mechanism | HeLa, HCT116, HL-60, K562, Molt4, NIH-3T3 and primary hepatocyte cultures | Unknown |
|
1213 | 15859953 | SRRARRSPRHLGSG | L | DPV10 | Human Intestinal mucin | Protein derived (Vectocell penetrating peptide fam | Unknown | Nucleus | Cys added to N -terminus for conjugation of report | Free | Unknown | Energy-dependent endocytic process involving cell membrane lipid rafts | HeLa, HCT116, HL-60, K562, Molt4, NIH-3T3 and primary hepatocyte cultures | Unknown |
|
1214 | 15859953 | LRRERQSRLRRERQSR | L | DPV15 | Human CAP37 | Protein derived (Vectocell penetrating peptide fam | Unknown | Nucleus | Cys added to N -terminus for conjugation of report | Free | Unknown | Energy-dependent endocytic process involving cell membrane lipid rafts | HeLa, HCT116, HL-60, K562, Molt4, NIH-3T3 and primary hepatocyte cultures | Unknown |
|
1215 | 15859953 | GAYDLRRRERQSRLRRRERQSR | L | DPV15b | Human CAP37 | Protein derived (Vectocell penetrating peptide fam | Unknown | Nucleus | Cys added to N -terminus for conjugation of report | Free | Unknown | Energy-dependent endocytic process involving cell membrane lipid rafts | HeLa, HCT116, HL-60, K562, Molt4, NIH-3T3 and primary hepatocyte cultures | Unknown |
|
1216 | 15859953 | GRKKRRQRRRPPQ | L | Tat (48-60) | HIV-1 | Protein derived | Cationic | Unknown | Cys added to N -terminus for conjugation of report | Free | Unknown | Energy-dependent endocytic process involving cell membrane lipid rafts | HeLa, HCT116, HL-60, K562, Molt4, NIH-3T3 and primary hepatocyte cultures | US 20040132970 |
|
1217 | 21359136 | VPMLK | L | Bip1 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | High (97% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1218 | 21359136 | VPTLK | L | Bip2 | Bax-binding domain of mouse Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Cytosole | Labelled with fluorescein | Free | Medium (61% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI, Jurkat, CHO A745, CHO K1, and HeLa | Unknown |
|
1219 | 21359136 | VPALR | L | Bip3 | Bax-binding domain of rat Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Medium (79% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1220 | 21359136 | VSALK | L | Bip4 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | High (90% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1221 | 21359136 | PMLKE | L | Bip5 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Medium (65% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1222 | 21359136 | VPALK | L | Bip6 | Bax-binding domain of cattle Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Medium (71% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1223 | 21359136 | VSLKK | L | Bip7 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1224 | 21359136 | VSGKK | L | Bip8 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1225 | 21359136 | KLPVM | L | Bip9 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | High | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI and HeLa | Unknown |
|
1226 | 21359136 | IPMIK | L | Bip10 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Medium (47% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1227 | 21359136 | KLGVM | L | Bip11 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1228 | 21359136 | KLPVT | L | Bip12 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1229 | 21359136 | VPMIK | L | Bip13 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1230 | 21359136 | IPALK | L | Bip14 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1231 | 21359136 | IPMLK | L | Bip15 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1232 | 21359136 | VPTLQ | L | Bip16 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Medium (70% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1233 | 21359136 | QLPVM | L | Bip17 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1234 | 21359136 | ELPVM | L | Bip18 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1235 | 21359136 | VPTLE | L | Bip19 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | High (80% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1236 | 21359136 | vptlk | D | Bip20 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
1245 | 16620748 | TKRRITPKDVIDVRSVTTEINT | L | Inv3 | Mycobacterium cell entry protein (Mce1A) | Protein derived | Unknown | Cytoplasm and nucleus membrane | Free (peptide coated FITC labelled microspheres) | Free | High | Endocytic pathway | HeLa | Unknown |
|
1247 | 16620748 | AEKVDPVKLNLTLSAAAEALTGLGDK | L | Inv5 | Mycobacterium cell entry protein (Mce1A) | Protein derived | Unknown | Cytoplasm and nucleus membrane | Free (peptide coated FITC labelled microspheres) | Free | High | Probably endocytic pathway | HeLa | Unknown |
|
1255 | 16620748 | TKRRITPKKVIDVRSVTTEINT | L | Inv3.4 | Mycobacterium cell entry protein (Mce1A) | Protein derived | Unknown | Cytoplasm and nucleus membrane | Free (peptide coated FITC labelled microspheres) | Free | Medium (relative to Inv3) | Probably endocytic pathway | HeLa | Unknown |
|
1256 | 16620748 | TKRRITPKDVIDVRSVTTKINT | L | Inv3.5 | Mycobacterium cell entry protein (Mce1A) | Protein derived | Unknown | Cytoplasm and nucleus membrane | Free (peptide coated FITC labelled microspheres) | Free | High (relative to Inv3) | Probably endocytic pathway | HeLa | Unknown |
|
1261 | 16620748 | HHHHHHTKRRITPKDVIDVRSVTTEINT | L | Inv3.10 | Mycobacterium cell entry protein (Mce1A) | Protein derived | Unknown | Cytoplasm and nucleus membrane | Free (peptide coated FITC labelled microspheres) | Free | High (relative to Inv3) | Probably endocytic pathway | HeLa | Unknown |
|
1296 | 16808894 | LLIILRRRIRKQAHAHSK | L | pVEC | Murine vascular endothelial-cadherin protein | Protein derived | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | High | Receptor independent endocytic pathway | AEC, HBCEC, End and Human bowes melanoma cells | Unknown |
|
1297 | 16808894 | ALIILRRRIRKQAHAHSK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Lower than pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1298 | 16808894 | LAIILRRRIRKQAHAHSK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Lower than pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1299 | 16808894 | LLAILRRRIRKQAHAHSK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Lower than pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1300 | 16808894 | LLIALRRRIRKQAHAHSK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Lower than pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1301 | 16808894 | LLIIARRRIRKQAHAHSK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Lower than pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1302 | 16808894 | LLIILARRIRKQAHAHSK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Greater than pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1303 | 16808894 | LLIILRARIRKQAHAHSK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Comparable to pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1304 | 16808894 | LLIILRRAIRKQAHAHSK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Greater than pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1305 | 16808894 | LLIILRRRARKQAHAHSK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Lower than pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1306 | 16808894 | LLIILRRRIARKQAHAHSK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Comparable to pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1307 | 16808894 | LLIILRRRIRAQAHAHSK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Comparable to pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1308 | 16808894 | LLIILRRRIRKAAHAHSK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Comparable to pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1309 | 16808894 | LLIILRRRIRKQaHAHSK | M | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Comparable to pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1310 | 16808894 | LLIILRRRIRKQAAAHSK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Lower than pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1311 | 16808894 | LLIILRRRIRKQAHaHSK | M | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Lower than pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1312 | 16808894 | LLIILRRRIRKQAHAASK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Comparable to pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1313 | 16808894 | LLIILRRRIRKQAHAHAK | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Greater than pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1314 | 16808894 | LLIILRRRIRKQAHAHSA | L | pVEC mutant | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Greater than pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1315 | 16808894 | KSHAHAQKRIRRRLIILL | L | Retro-pVEC | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Lower than pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1316 | 16808894 | lliilrrrirkqahahsk | D | D form of pVEC | Murine vascular endothelial-cadherin protein | Protein derived | Probably Amphipathic | Prabably cytoplasm and nucleus | Labelled with fluorescein | Amidation | Comparable to pVEC | Probably receptor independent endocytic pathway | Human bowes melanoma cells | Unknown |
|
1381 | 17984975 | MVRRFLVTLRIRRACGPPRVRV | L | ARF(1-22) | P14ARF protein | Protein derived | Unknown | Punctual/vesicular distribution (vesicles) | Labelled with fluorescein | Amidation | High, comparable to that of TP10 | Endocytic pathway | MCF-7 and MDA MB 231 | Unknown |
|
1382 | 17984975 | FVTRGCPRRLVARLIRVMVPRR | L | ARF(1-22) scr | P14ARF protein | Protein derived | Unknown | Punctual/vesicular distribution (vesicles) | Labelled with fluorescein | Amidation | Comparable to ARF (1-22) | Endocytic pathway | MCF-7 and MDA MB 231 | Unknown |
|
1396 | 11084031 | RRRRNRTRRNRRRVRGC | L | FHV coat (35-49) | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Comparable with that of the Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1397 | 11084031 | TRRQRTRRARRNRGC | L | HTLV -II Rex(4 –16) | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Comparable with that of the Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1398 | 11084031 | KMTRAQRRAAARRNRWTARGC | L | BMV GAG | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Comparable with that of the Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1399 | 11084031 | KLTRAQRRAAARKNKRNTRGC | L | CCMV GAG | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Moderate relative to Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1400 | 11084031 | NAKTRRHERRRKLAIERGC | L | P22 N | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Moderate relative to Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1401 | 11084031 | MDAQTRRRERRAEKQAQWKAANGC | L | LAMBDA N (1-22) | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Less relative to Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1402 | 11084031 | TAKTRYKARRAELIAERRGC | L | PHI 21 N (12-29) | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Less relative to Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1403 | 11084031 | SQMTRQARRLYBGC | L | Human U2AF (142-153) | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | No uptake observed | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1404 | 11084031 | KRRIRRERNKMAAAKSRNRRRELTDTGC | L | Human c Fos (139-164) | DNA binding peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Unknown | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1405 | 11084031 | RIKAERKRMRNRIAASKSRKRKLERIARGC | L | Human c Jun (252-279) | DNA binding peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Unknown | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1406 | 11084031 | KRARNTEAARRSRARKLQRMKQGC | L | Yeast GCN 4 (231-252) | DNA binding peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Less relative to Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
1417 | 11731788 | KETWWETWWTEWSQPKKKRKV | L | Pep-1 | Trp rich cluster + SV40 NLS | Chimeric | Amphipathic | Nucleus | Acetylation | Cysteamide at C-Terminus (FITC labelling) | Unknown | Non-endocytic pathway | HS-68 and NIH-3T3 | Unknown |
|
1418 | 20188697 | KETWFETWFTEWSQPKKKRKV | L | Pep-2 | Trp rich cluster + SV40 NLS | Chimeric | Amphipathic | Probably nucleus | Acetylation | Cysteamide at C-Terminus (FITC labelling) | Unknown | Probably non-endocytic pathway | HeLa | Unknown |
|
1419 | 20188697 | KWFETWFTEWPKKRK | L | Pep-3 | Trp rich cluster + SV40 NLS | Chimeric | Amphipathic | Probably nucleus | Acetylation | Cysteamide at C-Terminus (FITC labelling) | Unknown | Probably non-endocytic pathway | HeLa | Unknown |
|
1422 | 9008163 | DAATATRGRSAASRPTQRPRAPARSASRPRRPVE | L | VP22 | HSV-1 envelop protein 22 | Protein derived | Unknown | Nucleus | Unknown | Unknown | Unknown | Non-endocytic pathway | Cos-1 cells | Unknown |
|
1423 | 12771197 | GALFLGFLGAAGSTMGAWSQPKKKRKV | L | MPG | HIV GP41 + SV 40 NLS | Chimeric | Amphipathic | Nucleus | Acetylation | Cysteamide at C-Terminus | Unknown | Non-endocytic pathway | HS-68, Cos-7 and HeLa | Unknown |
|
1424 | 12771197 | GALFLGFLGAAGSTMGAWSQPKSKRKV | L | MPG Mutant | HIV GP41 + SV 40 NLS | Chimeric | Amphipathic | Nucleus | Acetylation | Cysteamide at C-Terminus | Lower than wilde type MPG | Non-endocytic pathway | HS-68, Cos-7 and HeLa | Unknown |
|
1427 | 10822301 | PLSSIFSRIGDP | L | PreS2 (41-52) | PreS2 domain of hepatitis-B virus surface antigens | Protein derived | Amphipathic | Cytosol | Conjugated with EGFP | Free | Unknown | Non-endocytic pathway | HepG2, HeLa and 293 cells | Unknown |
|
1428 | 10822301 | PSSSSSSRIGDP | L | PreS2 3S Mutant | PreS2 domain of hepatitis-B virus surface antigens | Protein derived | Non-amphipathic | Cytosol | Conjugated with EGFP | Free | Unknown | Probably non-endocytic pathway | HepG2, HeLa and 293 cells | Unknown |
|
1430 | 21365733 | VELPPPVELPPPVELPPP | L | Sweet Arrow Protein (SAP) (E) | Maize gamma-Zein | Protein derived | Amphipathic | Punctuated distribution (vesicles) | Labelled with fluoresceine/ rhodamine | Free | Comparable to L-SAP | Lipid raft caveolae mediated endocytic process | HeLa, A549, BJ and HT cells | Unknown |
|
1431 | 12119035 | ALWMTLLKKVLKAAAKAALNAVLVGANA | L | Dermaseptin S4 | Dermaseptins family | Protein derived | Antimicrobial | Cytoplasm | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
1432 | 12119035 | ALWKTLLKKVLKA | L | S4(13) | Dermaseptin S4 | Protein derived | Antimicrobial | Cytoplasm | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
1433 | 12119035 | ALWKTLLKKVLKAPKKKRKV | L | S4(13)-PV | Dermaseptin S4 peptide + SV40 NLS | Chimeric | Karyophilic | Cytoplasm and nucleus | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
1434 | 12119035 | PKKKRKVALWKTLLKKVLKA | L | PV-S4(13) | SV40 NLS + dermaseptin S4 peptide | Chimeric | Karyophilic | Cytoplasm and nucleus | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
1435 | 12119035 | VKRKKKPALWKTLLKKVLKA | L | PV reverse-S4(13) | Dermaseptin S4 peptide + SV40 NLS reverse | Chimeric | Unknown | Cytoplasm | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
1436 | 12119035 | RQARRNRRRALWKTLLKKVLKA | L | RR-S4(13) | Rev ARM + Dermaseptin S4 peptide | Chimeric | Karyophilic | Cytoplasm and nucleus | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
1437 | 12119035 | RQARRNRRRC | L | Rev ARM | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
1438 | 12119035 | GRKKRRQRRRPPQC | L | Tat ARM | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
1440 | 21029412 | EEE | L | Glu | Unknown | Synthetic | Unknown | Cytoplasm | Free | Labelled with FITC | Low | Receptor-independent non-endocytic pathway | DU-145 and LNCaP | US 20100137187 |
|
1441 | 21029412 | EEEAA | L | Glu-Ala | Unknown | Synthetic | Unknown | Cytoplasm | Free | Labelled with FITC | Low | Receptor-independent non-endocytic pathway | DU-145 and LNCaP | US 20100137187 |
|
1442 | 21029412 | EEEAAKKK | L | Glu-Lys | Unknown | Synthetic | Unknown | Cytoplasm | Free | Labelled with FITC | Lower than Glu-Oct-6 but higher than Oct-6 | Receptor-independent non-endocytic pathway | DU-145 and LNCaP | US 20100137187 |
|
1447 | 17622242 | MVTVLFRRLRIRRACGPPRVRV | L | M918 | C-terminus of p14ARF protein | Protein derived | Amphipathic | Vesicles | Labelled with fluoresceine | Amidation | Higher than Penetratin | Mainly via endocytic process,and in particular macropinocytosis, but independent of glycosaminoglycans on the cell surface | HeLa, MCF-7, CHO K1, and Hifko cells | Unknown |
|
1450 | 12204694 | VQRKRQKLMP | L | NF-kB | Transcription factor NF-kB | Protein derived | Cationic | Cytoplasm and nucleus, nucleolus | Labelled with fluoresceine | Amidation | Lower than Oct-6 | Energy dependent endocytic pathway | MCF-7 | Unknown |
|
1451 | 12204694 | SKKKKTKV | L | TFIIE BETA | Transcription factor TFIIE-beta | Protein derived | Cationic | Cytoplasm | Labelled with fluoresceine | Amidation | Lower than Oct-6 | Energy dependent endocytic pathway | MCF-7 | Unknown |
|
1455 | 12204694 | ERKKRRRE | L | HATF3 | Transcription factor HATF-3 | Protein derived | Cationic | Unknown | Labelled with fluoresceine | Amidation | Lower than Oct-6 | Energy dependent endocytic pathway | MCF-7 | Unknown |
|
1480 | 12783857 | RGGRLSYSRRRFSTSTGR | L | SynB1 | protegrin | Protein derived | Antimicrobial | Endocytic vesicles | Labelled with NBD and TAMRA | Free | Lower than pAntp-(43–58) and SynB5 | Adsorptive-mediated endocytic process | K562 cells | Unknown |
|
1482 | 12783857 | RRLSYSRRRF | L | SynB3 | protegrin | Protein derived | Antimicrobial | Endocytic vesicles | Labelled with NBD and TAMRA | Free | Lower than pAntp-(43–58) and SynB5 | Adsorptive-mediated endocytic process | K562 cells | Unknown |
|
1484 | 12783857 | RGGRLAYLRRRWAVLGR | L | SynB5 | protegrin | Protein derived | Antimicrobial | Endocytic vesicles | Labelled with NBD and TAMRA | Free | Lower than pAntp-(43–58) | Adsorptive-mediated endocytic process | K562 cells | Unknown |
|
1485 | 12783857 | RQIKIWFQNRRMKWKK | L | Penetratin {pAntp-(43–58)} | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Endocytic vesicles | Labelled with NBD and TAMRA | Free | Unknown | Adsorptive-mediated endocytic process | K562 cells | Unknown |
|
1489 | 14963039 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESC | L | LL-37 | Human cathelin-associated peptide | Protein derived | Antimicrobial | Nucleus | Unknown | Amidation | Unknown | Membrane raft endocytosis and proteoglycan-dependent endocytic process | COS-7, HFL-1 and CHO-K1 cells | Unknown |
|
1490 | 11716681 | RQIKIWFQNRRMKWKK | L | Penetratin {pAntp-(43–58)} | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Cytoplasm and nucleus | Biotinylation | Amidation | Unknown | Non-endocytic pathway | Human bowes melanoma cells | Unknown |
|
1491 | 11716681 | RVIRVWFQNKRCKDKK | L | pISL | Homeodomain of the rat transcription factor Islet- | Protein derived | Amphipathic | Cytoplasm and nucleus | Biotinylation | Amidation | Comparable to penetratin | Non-endocytic pathway | Human bowes melanoma cells | Unknown |
|
1493 | 12417587 | TRSSRAGLQWPVGRVHRLLRKGGC | L | BF2d | Buforin 2 analouge | Protein derived | Antimicrobial | Cytosol and nucleus | Free | Labelled with Texas Red | Comparable to Tat (47-57) | Unknown probably non endocytic pathway | HeLa or TM12 cells | Unknown |
|
1500 | 11084031 | GRRRRRRRRRPPQ | L | R9-TAT | HIV 1 Tat derivative | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-Terminal cysteine labelled with fluorescein | High comparable to Tat(48-60) | Probably non-endocytic pathway | RAW 264.7 cells | Unknown |
|
1503 | 16808988 | MLLLTRRRST | L | BagP | Bag1 protein | Protein derived | Cationic | Unknown | Biotinylated or TMR labeling | Free | Unknown | Energy dpendent probably endocytic pathway | Daudi, K562 and FM3 cells | Unknown |
|
1505 | 11118031 | TSPLNIHNGQKL | L | HN-1 | Phage Display Library | Synthetic | Unknown | Cytoplasm | Labelled with fluoresceine/ FITC/texas red | Amidation | Unknown | Receptor mediated endocytic pathway | MDA138Tu, MDA159Tu, MDA167Tu, MDA686Tu, MDA1986Tu, and MDA177Tu cells | Unknown |
|
1506 | Unknown | GLRKRLRKFRNKIKEK | L | Sc18 | CAMP cathelicidin (106-121) | Protein derived | Cationic amphipathic | Vesicles | Labelled with fluoresceine | Amidation | High | Energy-dependent endocytic pathway | HeLa, HEK 293 and MCF-7 | Unknown |
|
1507 | Unknown | GLLEALAELLEGLRKRLRKFRNKIKEK | L | N-E5L-Sc18 | N-terminal region of the HA2 subunit + Sc18 | Chimeric | Unknown | Cytosol and nucleus | Labelled with fluoresceine | Amidation | Unknown | Endocytic pathway | HeLa, HEK 293 and MCF-8 | Unknown |
|
1508 | 19084505 | CVQWSLLRGYQPC | L | S41 | Phage display Library | Synthetic | Unknown | Co-localizes with lipid rafts | Labelled with FITC | Unknown | Unknown | Lipid rafts dependent endocytic process | N2A and CGNs cells | Unknown |
|
1509 | 15054781 | VRLPPP | L | PolyP 1 | Maize gamma-Zein | Protein derived | Amphipathic | Punctate cytoplasmic distribution (vesicles) | Labelled with fluoresceine | Free | Low | Probably endocytic pathway | HeLa | Unknown |
|
1510 | 15054781 | VRLPPPVRLPPP | L | PolyP 2 | Maize gamma-Zein | Protein derived | Amphipathic | Punctate cytoplasmic distribution (vesicles) | Labelled with fluoresceine | Free | Low | Probably endocytic pathway | HeLa | Unknown |
|
1511 | 15054781 | VRLPPPVRLPPPVRLPPP | L | PolyP 3 (SAP) | Maize gamma-Zein | Protein derived | Amphipathic | Punctate cytoplasmic distribution (vesicles) | Labelled with fluoresceine | Free | High | Endocytic pathway | HeLa | Unknown |
|
1512 | 15054781 | VHLPPP | L | PolyP 4 | Maize gamma-Zein | Protein derived | Amphipathic | Punctate cytoplasmic distribution (vesicles) | Labelled with fluoresceine | Free | Low | Probably endocytic pathway | HeLa | Unknown |
|
1513 | 15054781 | VHLPPPVHLPPP | L | PolyP 5 | Maize gamma-Zein | Protein derived | Amphipathic | Punctate cytoplasmic distribution (vesicles) | Labelled with fluoresceine | Free | Low | Probably endocytic pathway | HeLa | Unknown |
|
1514 | 15054781 | VHLPPPVHLPPPVHLPPP | L | PolyP 6 | Maize gamma-Zein | Protein derived | Amphipathic | Punctate cytoplasmic distribution (vesicles) | Labelled with fluoresceine | Free | Low | Probably endocytic pathway | HeLa | Unknown |
|
1515 | 15054781 | VKLPPP | L | PolyP 7 | Maize gamma-Zein | Protein derived | Amphipathic | Punctate cytoplasmic distribution (vesicles) | Labelled with fluoresceine | Free | Low | Probably endocytic pathway | HeLa | Unknown |
|
1516 | 15054781 | VKLPPPVKLPPP | L | PolyP 8 | Maize gamma-Zein | Protein derived | Amphipathic | Punctate cytoplasmic distribution (vesicles) | Labelled with fluoresceine | Free | Low | Probably endocytic pathway | HeLa | Unknown |
|
1517 | 15054781 | VKLPPPVKLPPPVKLPPP | L | PolyP 9 | Maize gamma-Zein | Protein derived | Amphipathic | Punctate cytoplasmic distribution (vesicles) | Labelled with fluoresceine | Free | Medium | Probably endocytic pathway | HeLa | Unknown |
|
1522 | 9350995 | DPKGDPKGVTVTVTVTVTGKGDPKPD | L | VT5 | Beta-sheet model peptide | Synthetic | Amphipathic | Unknown | Labelled with fluoresceine | Unknown | Unknown | Clathrin dependent endocytic process | Calf aortic endothelial cells | Unknown |
|
1523 | 16272160 | CSIPPEVKFNPFVYLI | L | C105Y | Alpha1-antitrypsin (359–374) | Protein derived | Unknown | Cytoplasm and nucleus, nucleolus | Labelled with fluoresceine/FITC | Amidation | Unknown | Clathrin- and caveolin-independent lipid raft-mediated endocytic process | HuH7, 3T3, and primary HTE cells | Unknown |
|
1527 | 18983137 | YKQCHKKGGKKGSG | L | (1-9)-(38-42) Crot | Retal snake venom (Crotamine) | Protein derived | Unknown | Nucleus and nucleolus | Labelled with rhodamine B dye | Free | Unknown | Receptor mediated endocytic process | HeLa | Unknown |
|
1528 | 18983137 | YKQCHKKGGXKKGSG | L | (1-9)-Ahx-(38-42) Crot | Retal snake venom (Crotamine) | Protein derived | Unknown | Nucleus and nucleolus | Labelled with rhodamine B dye | Free | Unknown | Receptor mediated endocytic process | HeLa | Unknown |
|
1529 | 18983137 | GSGKKGGKKHCQKY | L | (42-38)-(9-1) Crot | Retal snake venom (Crotamine) | Protein derived | Unknown | Probably nucleus and nucleolus | Labelled with rhodamine B dye | Free | Unknown | Receptor mediated endocytic process | HeLa | Unknown |
|
1533 | 17463227 | LIRLWSHLIHIWFQNRRLKWKKK | L | EB-1 | Antennapedia homeodomain of drosophila (Penetratin | Protein derived | Amphipathic | Cytosol | Unknown | Amidation | Unknown | Endocytic pathway | HepG2 cells | Unknown |
|
1536 | 17268054 | GPFHFYQFLFPPV | L | 435B peptide | Phage display | Synthetic | Unknown | Unknown | FITC-Labelling | Free | On A431 cells, similar to Tat but on HeLa and CHO | Caveolae/raft-dependent endocytic process | Human carcinoma A431, HeLa and CHO | Unknown |
|
1537 | 17268054 | GSPWGLQHHPPRT | L | 439A peptide | Phage display | Synthetic | Unknown | Unknown | FITC-Labelling | Free | On A431 cells, 10 fold lower than Tat but on HeLa | Caveolae/raft-dependent endocytic process | Human carcinoma A431, HeLa and CHO | Unknown |
|
1542 | 9287160 | MGLGLHLLVLAAALQGAWSQPKKKRKV | L | Peptide 1 | Designed (Signal sequence + NLS) | Chimeric | Amphipathic | Nucleus | Acetylation | Cysteamide | Unknown | Non-endocytic pathway (direct translocation) | HS-68 Cells | Unknown |
|
1543 | 9287160 | MGLGLHLLVLAAALQGAKKKRKV | L | Peptide 2 | Designed (Signal sequence + NLS) | Chimeric | Amphipathic | Nucleus | Acetylation | Cysteamide | Unknown | Non-endocytic pathway (direct translocation) | HS-68 Cells | Unknown |
|
1544 | 19388672 | WEAALAEALAEALAEHLAEALAEALEALAA | L | GALA | Designed | Synthetic | Amphipathic | Cytosol | FITC labelled | Unknown | Unknown | Endocytic pathway | HeLa | Unknown |
|
1548 | Unknown | CGAYDLRRRERQSRLRRRERQSR | L | DPV15b | Human CAP37 | Protein derived | Unknown | Cytoplasm | Unknown | Unknown | Unknown | Endocytic pathway | HeLa, PC-3, NCI-H460 and MDA-MB-231 | US 20090186802 |
|
1549 | Unknown | RKKRRRESRKKRRRESC | L | DPV3 | Human Superoxide dismutase | Protein derived | Unknown | Cytoplasm | Unknown | Unknown | Unknown | Endocytic pathway | HeLa, PC-3, NCI-H460 and MDA-MB-231 | US 20090186802 |
|
1550 | Unknown | CVKRGLKLRHVRPRVTRDV | L | DPV1048 | Unknown | Protein derived | Unknown | Cytoplasm | Unknown | Unknown | Unknown | Endocytic pathway | HeLa, PC-3, NCI-H460 and MDA-MB-231 | US 20090186802 |
|
1553 | Unknown | PPKKSAQCLRYKKPE | L | Secretory leukoprotease inhibitor derived PTD | Secretory leukoprotease inhibitor | Protein derived | Unknown | Nucleus | FITC Labeling | Unknown | Unknown | Non-endocytic pathway | P5 DRG neurons | US20110107443 |
|
1554 | Unknown | DPVDTPNPTRRKPGK | L | Secretory leukoprotease inhibitor derived PTD | Secretory leukoprotease inhibitor | Protein derived | Unknown | Nucleus | FITC Labeling | Unknown | Unknown | Non-endocytic pathway | P5 DRG neurons | US20110107443 |
|
1555 | 15346201 | KRVSRNKSEKKRR | L | hClock-(35-47) | Human Clock protein DNA-binding peptide | Protein derived | Cationic | Cytoplasm and nucleus, but mainly in the nucleus with a nucleolar accumula | FITC Labeling | Unknown | Similar to Tat (48-60) | Non-endocytic pathway | ECV-304 and the primary neuroglial cells | Unknown |
|
1556 | 15781181 | GRRHHCRSKAKRSRHH | L | hPER1- PTD (830-846) NLS | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Non-endocytic pathway | CHO | US 7754678 |
|
1557 | 15781181 | SARHHCRSKAKRSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
1558 | 15781181 | SRAHHCRSKAKRSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
1559 | 15781181 | SRRAHCRSKAKRSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
1560 | 15781181 | SRRHACRSKAKRSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
1561 | 15781181 | SRRHHARSKAKRSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
1562 | 15781181 | SRRHHCRAKAKRSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
1563 | 15781181 | SRRHHCRSAAKRSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
1564 | 15781181 | SRRHHCRSKAARSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
1565 | 15781181 | SRRHHCRSKAKASRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
1566 | 15781181 | SRRHHCRSKAKRARHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
1567 | 15781181 | SRRHHCRSKAKRSAHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
1568 | 15781181 | RRHHCRSKAKRSR | L | hPER1-PTD | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
1582 | 21440624 | MIIYRDLISH | L | TCTP (1-10) deletion mutant | Human translationally controlled tumor protein | Protein derived | Unknown | Cytoplasm and nucleus | Rhodamine labeling | Amidation | Unknown | Endocytic pathway | HeLa | US 20100168034 |
|
1795 | 21873420 | GGVCPKILKKCRRDSDCPGACICRGNGYCGSGSD | L & C | MCoTI-II(MCo) | Momordica cochinchinensis trypsin inhibitor II | Protein derived | Unknown | Endosomal compartments (vesicles) | Lysine rsidue labeled with Alexa-488 | Cyclization | Unknown | Endocytic pathway | RAW 264.7 and MCF-7 | Unknown |
|
1796 | 21873420 | GGVCPKILAACRRDSDCPGACICRGNGYCGSGSD | L & C | MCoKKAA double mutant | Momordica cochinchinensis trypsin inhibitor II | Protein derived | Unknown | Endosomal compartments (vesicles) | Lysine rsidue labeled with Alexa-488 | Cyclization | Unknown | Endocytic pathway | RAW 264.7 and MCF-7 | Unknown |
|
1797 | 21873420 | GGVCPAILKKCRRDSDCPGACICRGNGYCGSGSD | L & C | MCoK6A mutant | Momordica cochinchinensis trypsin inhibitor II | Protein derived | Unknown | Endosomal compartments (vesicles) | Lysine rsidue labeled with Alexa-488 | Cyclization | Unknown | Endocytic pathway | RAW 264.7 and MCF-7 | Unknown |
|
1798 | 21873420 | GGVCPKILAKCRRDSDCPGACICRGNGYCGSGSD | L & C | MCoK9A mutant | Momordica cochinchinensis trypsin inhibitor II | Protein derived | Unknown | Endosomal compartments (vesicles) | Lysine rsidue labeled with Alexa-488 | Cyclization | Unknown | Endocytic pathway | RAW 264.7 and MCF-7 | Unknown |
|
1799 | 21873420 | GGVCPKILKACRRDSDCPGACICRGNGYCGSGSD | L & C | MCoK10A mutant | Momordica cochinchinensis trypsin inhibitor II | Protein derived | Unknown | Endosomal compartments (vesicles) | Lysine rsidue labeled with Alexa-488 | Cyclization | Unknown | Endocytic pathway | RAW 264.7 and MCF-7 | Unknown |
|
1800 | 21873420 | GLPVCGETCVGGTCNTPGCKCSWPVCTRN | L & C | kT20K mutant | O. affinis | Protein derived | Unknown | Endosomal compartments (vesicles) | Lysine rsidue labeled with Alexa-488 | Cyclization | Unknown | Endocytic pathway | RAW 264.7 and MCF-7 | Unknown |
|
1801 | 21873420 | GLPVCGETCVGGTCNTPGCTCSWPKCTRN | L & C | kV25K mutant | O. affinis | Protein derived | Unknown | Endosomal compartments (vesicles) | Lysine rsidue labeled with Alexa-488 | Cyclization | Unknown | Endocytic pathway | RAW 264.7 and MCF-7 | Unknown |
|
1802 | 21873420 | GRCTKSIPPICFPD | L & C | SFTI-1 | Sunflower trypsin inhibitor 1 | Protein derived | Unknown | Endosomal compartments (vesicles) | Lysine rsidue labeled with Alexa-488 | Cyclization | Unknown | Endocytic pathway | RAW 264.7 and MCF-7 | Unknown |
|
1804 | 15937518 | RQIKIWFQNRRMKWKKTYADFIASGRTGRRNAI | L | pAntp–PKI | Antennapedia homeodomain of drosophila and protein | Protein derived | Unknown | Unknown | Rhodamine-labelled | Free | Less than Polyarginine-PKI and transportan-PKI but | Lipid raft-dependent but clathrin-independent endocytic process | CHO K1, HeLa, A549 cells | Unknown |
|
1805 | 15937518 | GRKKRRQRRRPPQ | L | Tat | HIV-1 | Protein derived | Cationic | Unknown | Rhodamine-labelled | Free | Less than polyarginine and pAntp but equal to tran | Lipid raft-dependent but clathrin-independent endocytic process | CHO K1, HeLa, A549 cells | Unknown |
|
1806 | 15937518 | GRKKRRQRRRPPQTYADFIASGRTGRRNAI | L | Tat-PKI | HIV-1 and protein kinase Inhibitor | Protein derived | Unknown | Unknown | Rhodamine-labelled | Free | Less than polyarginine-PKI, Antp-PKI and Transport | Lipid raft-dependent but clathrin-independent endocytic process | CHO K1, HeLa, A549 cells | Unknown |
|
1830 | 19733192 | GGGARKKAAKAARKKAAKAARKKAAKAARKKAAKA | L | POD | Designed | Synthetic | Unknown | Punctate pattern (vesicles) | Free | GFP | Unknown | Endocytic pathways but more than one mechanism may possible | Human embryonic retinoblasts, A549 | Unknown |
|
1831 | 19707187 | GRKKRRQRRRPPQC | L | HIV-1 Tat (48–60) | HIV-1 | Protein derived | Cationic | Only punctate distribution (vesicles) | Free | Alexa 488 labeling at glycyl cysteine sequence | Unknown | Endocytic pathway (Macropinocytosis) | CHO-K1, HeLa and Jurkat | US 20040132970 |
|
1833 | 19707187 | RRRRNRTRRNRRRVRGC | L | FHV coat (35–49) | Flock House Virus | Protein derived | Cationic | Punctate distribution (vesicles) with diffuse flurescence in cytosole and | Free | Alexa 488 labeling at glycyl cysteine sequence | 2.7–6.4 times more than the Rev peptide | Endocytic pathway (Macropinocytosis) | CHO-K1, HeLa and Jurkat | Unknown |
|
1842 | 12411431 | GRKKRRQRRRPP | L | Tat (48-59) | HIV-1 | Protein derived | Cationic | Punctate distribution (vesicles) | Fluorescein-tagged | Free | Unknown | Energy dependent endocytic pathway | HeLa and CHO K1 and Jurkat | Unknown |
|
1843 | 12411431 | RRRRRRRRR | L | R9 | Positively charged sequence | Synthetic | Cationic | Punctate distribution (vesicles) | Fluorescein-tagged | Free | Unknown | Energy dependent endocytic pathway | HeLa | Unknown |